Volume 8, Issue 2, March 2020, Page: 73-77
Application of Various Equations for Estimating GFR in Patients with Type 1 Diabetes
M. V. Kaplanian, Stavropol State Medical University of Russian Ministry of Health, Stavropol, Russian Federation
A. B. Hodzhayan, Stavropol State Medical University of Russian Ministry of Health, Stavropol, Russian Federation
M. G. Gevandova, Stavropol State Medical University of Russian Ministry of Health, Stavropol, Russian Federation
K. S. Elbekyan, Stavropol State Medical University of Russian Ministry of Health, Stavropol, Russian Federation
E. V. Kaplanova, Kuban State University, Krasnodar, Russian Federation
K. R. Amlaev, Stavropol State Medical University of Russian Ministry of Health, Stavropol, Russian Federation
Received: Apr. 12, 2019;       Accepted: Jun. 23, 2019;       Published: Mar. 17, 2020
DOI: 10.11648/j.ajim.20200802.15      View  200      Downloads  93
Abstract
To compare different methods of estimating glomerular filtration rate (GFR) calculated by creatinine and cystatin C in patients with type 1 diabetes with normal and moderately decreased renal filtration function. The study involved 57 patients with type 1 diabetes, 37 men and 20 women, aged from 21 to 57 years (median 30 years), with disease duration after diagnosis from 33 to 2 years (median 8 years). The control group comprised 15 non-diabetic people aged 19 to 42 years (median – 28 years), with normal levels of albuminuria and blood creatinine. The majority of patients with type 1 diabetes were found to have decompensated diabetes mellitus. The mean value of glycated hemoglobin in patients was 8%. The renal glomerular function was estimated by level of GFR and triple testing of urine albumin excretion. Renal tubular function in type 1 diabetes was tested by examining serum cystatin C. GFR estimating equations, which did not include serum of cystatin C produced higher GFR. As a result, the majority of patients had normal or elevated GFR showing hyperfiltration. Using cystatin-C-based equations resulted in a several-fold reduction in the number of patients with hyperfiltration and increased number of cases with GFR below 90 ml/min/m2. The assessment of the relationship between SDMA and GFR showed negative correlation with both cystatin-C-based and creatinine-based equations. These findings revealed that GFR estimating equations based on both creatinine and cystatin C produce more accurate results compared with the reference estimating equations.
Keywords
Diabetic Nephropathy, Type 1 Diabetes, Cystatin C, Symmetric Dimethylarginine
To cite this article
M. V. Kaplanian, A. B. Hodzhayan, M. G. Gevandova, K. S. Elbekyan, E. V. Kaplanova, K. R. Amlaev, Application of Various Equations for Estimating GFR in Patients with Type 1 Diabetes, American Journal of Internal Medicine. Vol. 8, No. 2, 2020, pp. 73-77. doi: 10.11648/j.ajim.20200802.15
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Dedov, I. I., Vikulova, OK, Sukhareva, O. Yu. Screening for diabetic nephropathy in the Russian Federation. In: Shestakova M. V., Dedov I. I. (Ed.) Diabetes mellitus and chronic kidney disease. M., 2009. P. 39-59.
[2]
Fioretto P., Caramori M. L., Mauer M. The kidneys in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007. Diabetologia. 2008; 51: 1051-1057.
[3]
Bondar I. A., Klimontov V. V. Functional morphology of the kidneys in diabetes mellitus. In the book: Shestakova M. V., Dedov II, ed. Diabetes mellitus and chronic kidney disease. M., 2009. p. 149-176.
[4]
Fioretto P., Sutherland D. E., Najafian B. et al. Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients. Kidney Int. 2006; 69: 907-912.
[5]
Viberti G. C., Wiseman M. J. The kidney in diabetes: significance of the early abnormalities. Clin. Endocrinol. Metab. 1986; 15: 753-782.
[6]
Microalbuminuria Collaborative Study Group. Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. Diabet. Med. 1999; 16: 918-925.
[7]
Stone M. L., Craig M. E., Chan A. K., Lee J. W., Verge C. F., Donaghue K. C. Natural history and risk factors for microalbuminuria in adolescents with type 1 diabetes: a longitudinal study. Diabetes Care 2006; 29: 2072-2077.
[8]
Jerums G., Panagiotopoulos S., Maclsaac R. J. Diabetic nephropathy: epidemiology and clinical description. In: Boner G., Cooper M. E., ed. Management of Diabetic Nephropathy. L., N.-Y. 2003. Р. 37-60.
[9]
Valmadrid C. T., Klein R., Moss S. E., Klein B. E. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch. Intern. Med. 2000; 160: 1093-1100.
[10]
Casiglia E., Zanette G., Mazza A., Donadon V., Donada C., Pizziol A., Tikhonoff V., Palatini P., Pessina A. C. Cardiovascular mortality in non- insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex- matched normal subjects. Eur. J. Epidemiol. 2000; 16: 677-684.
[11]
Torffvit O., Lovestam-Adrian M., Agardh E., Agardh C. D. Nephropathy, but not retinopathy, is associated with the development of heart disease in Type 1 diabetes: a 12-year observation study of 462 patients. Diabet. Med. 2005; 22 (6): 723-729.
[12]
Groop P. H., Thomas M. C., Moran J. L., Wadèn J., Thorn L. M., Mäkinen V. P., Rosengård-Bärlund M., Saraheimo M., Hietala K., Heikkilä O., Forsblom C.; FinnDiane Study Group. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes. 2009; 58: 1651-1658.
[13]
Mukhin N. A., Fomin V. V., Moiseev S. V. Microalbuminuria is a universal marker of poor prognosis. Clinical medicine. 2008; 11: 4-9.
[14]
Konyukh E. A., Paramonova N. S. Clinical features of acute and chronic glomerulonephritis in children with endothelial dysfunction. Zhurnal GrGMU. 2010; 2: 149 (in Russ.).
[15]
Knight E. L., Verhave J. C., Spiegelman D., Hillege H. L., de Zeeuw D., Curhan G. C., de Jong P. E. Factors in fluencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004; 65: 1416-1421.
[16]
Lemieux C., Maliba R., Favier J., Théorêt J. F., Merhi Y., Sirois M. G. Angiopoietins can directly activate endothelial cells and neutrophils to promoteproinflammatory responses. Blood. 2005; 105 (4): 1523-1530.
[17]
Stevens L. A., Schmid C. H., Greene T., Li L., Beck G. J., Joffe M. M., Froissart M., Kusek J. W., Zhang Y. L., Coresh J., Levey A. S. Factors other than glo-merularfiltration rate affect serum cystatin C levels. Kidney Int. 2009; 75: 652-660.
[18]
Magee G. M., Bilous R. W., Cardwell C. R., Hunter S. J., Kee F., Fogarty D. G. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A metaanalysis. Diabetologia. 2009; 52: 691-697.
[19]
Köttgen A., Selvin E., Stevens L. A., Levey A. S., Van Lente F., Coresh J. Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Am. J. Kidney Dis. 2008; 51: 385-394.
[20]
Stam F., van Guldener C., Dekker J. M., Heine R. J., Bouter L. M., Stehouwer C. D. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J. Am. Soc. Nephrol. 2006; 2: 537-545.
[21]
Berezinets O. L., Rossolovskiy A. N., Blyumberg B. I. Modern aspects of future developments and the progression of coronary artery disease in patients with chronic kidney disease. Byulleten' meditsinskikh Internet-konferentsiy. 2014; 4 (1): 72-74 (in Russ.).
[22]
Landray M. J., Wheeler D. S., Newman D. J., Blann A. D., McGlynn F. J., Ball S., Townend J. N., Baigent C. Inflammation, Endothelial dysfunction and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) Study. Am. J. Kidney Dis. 2004; 43: 244-253.
[23]
Martens C. R., Edwards D. G. Peripheral Vascular Dysfunction in Chronic Kidney Disease. Cardiol. Res. Pract. 2011; 1: 2-6.
[24]
Böger R. H., Lentz S. R., Bode-Böger S. M., Knapp H. R., Haynes W. G. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst (e) inaemia in humans. Clin. Sci (Colch). 2001; 100 (2): 161-167.
Browse journals by subject